Isracann Advances Cannabis Project Characterization in Israel
--Early reports already impacting decisions resulting in projected process efficiencies and cost savings VANCOUVER, British Columbia, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an …